Dr. Vance Sohn Appointed Director of MedStar Georgetown Cancer Institute at MedStar Washington Hospital Center

Dr. Sohn brings an extensive background in surgical oncology, leadership, education, and clinical research.

WASHINGTON — Vance Sohn, MD, is the new director of the MedStar Georgetown Cancer Institute at MedStar Washington Hospital Center. With more than two decades of experience, Dr. Sohn brings a distinguished background in surgical oncology, clinical research, and healthcare leadership. He most recently served as a surgical oncologist with the U.S. Department of Veterans Affairs, professor of Surgery at the Uniformed Services University, and vice president of Medical Affairs at a clinical research organization.

“I’m excited to join the exceptional team of clinicians, researchers, caregivers, and staff members of the MedStar Georgetown Cancer Institute, and will continue building on its reputation as the region’s leader in world-class cancer care,” said Dr. Sohn. “MedStar Health is familiar territory for me as I’m a proud graduate of Georgetown University School of Medicine, which is MedStar Health’s medical education and clinical partner. I’m honored to return and help lead transformative efforts that will continue to elevate cancer care and our community.”

Dr. Sohn specializes in surgical oncology, with expertise in cutaneous, gastrointestinal, and sarcoma malignancies.

A graduate of the United States Military Academy at West Point, he completed his General Surgery residency at Madigan Army Medical Center and a Surgical Oncology fellowship at MD Anderson Cancer Center. He obtained his MBA from the University of Tennessee.

Throughout his military career, Dr. Sohn held key leadership roles, including program director, chief of General Surgery, and various positions within the Office of the Surgeon General. He retired from the U.S. Army in 2024 after a career marked by advancing cancer care at local, regional, and national levels.